Beta
Bisphosphonates
medication Under reviewBisphosphonates are a class of antiresorptive medications used to slow bone breakdown by inhibiting osteoclast-mediated bone resorption. They bind strongly to hydroxyapatite in bone, which helps reduce bone turnover and preserve bone mineral density over time. Common agents include alendronate, risedronate, ibandronate, and zoledronic acid. In healthy adults, bisphosphonates are primarily used to prevent and treat osteoporosis-related bone loss, especially after menopause or with aging, and to reduce fracture risk in people at high risk of fragility fractures. They are not nutritional supplements in the usual sense; they are prescription drugs with well-established bone-specific effects and a comparatively narrow clinical use profile.
Research summary
Human clinical evidence is strong that bisphosphonates increase bone mineral density and reduce vertebral and nonvertebral fracture risk in patients with osteoporosis, with effects seen across multiple randomized trials and meta-analyses. The best-supported benefits are bone health and fracture prevention, with some evidence suggesting a time-to-benefit of roughly a year for preventing nonvertebral fractures in postmenopausal women with osteoporosis. Safety is generally good in appropriate patients, but important adverse effects are documented, especially gastrointestinal irritation with oral agents, transient flu-like acute-phase reactions with some intravenous agents, and rare serious events such as atypical femur fractures and osteonecrosis of the jaw with longer-term use. Some analyses have raised concern about atrial fibrillation with intravenous zoledronic acid, but this has not been consistently confirmed across trials.
Reported Benefits
No reports yet
Be the first to report this effect and help the community.
Add Bisphosphonates to your stack to report effects
Long-Term Use of Bisphosphonates in Osteoporosis
Adler RA et al.
Effect of bisphosphonates on orthodontic tooth movement: an umbrella review.
StatPearls
Osteoporosis and osteoporosis therapies as determinants of implant fixation failure in arthroplasty and spinal fusion constructs: a position statement from the Fracture Working Group of the Council of Scientific Advisors of the International Osteoporosis Foundation.
International Osteoporosis Foundation
Reconsidering the Benefits of Osteoporosis Treatment: The Case of Bisphosphonates.
Cummings SR et al.
Time to Benefit of Bisphosphonate Therapy for the Prevention of Nonvertebral Fractures in Postmenopausal Women With Osteoporosis
Liu J et al.
Reported Side Effects
No reports yet
Be the first to report this effect and help the community.
Add Bisphosphonates to your stack to report effects
Long-Term Use of Bisphosphonates in Osteoporosis
Adler RA et al.
No reports yet
Be the first to report this effect and help the community.
Add Bisphosphonates to your stack to report effects
Long-Term Use of Bisphosphonates in Osteoporosis
Adler RA et al.
No reports yet
Be the first to report this effect and help the community.
Add Bisphosphonates to your stack to report effects
Osteoporosis and osteoporosis therapies as determinants of implant fixation failure in arthroplasty and spinal fusion constructs: a position statement from the Fracture Working Group of the Council of Scientific Advisors of the International Osteoporosis Foundation.
International Osteoporosis Foundation
No reports yet
Be the first to report this effect and help the community.
Add Bisphosphonates to your stack to report effects
Osteoporosis and osteoporosis therapies as determinants of implant fixation failure in arthroplasty and spinal fusion constructs: a position statement from the Fracture Working Group of the Council of Scientific Advisors of the International Osteoporosis Foundation.
International Osteoporosis Foundation
No reports yet
Be the first to report this effect and help the community.
Add Bisphosphonates to your stack to report effects
Osteoporosis and osteoporosis therapies as determinants of implant fixation failure in arthroplasty and spinal fusion constructs: a position statement from the Fracture Working Group of the Council of Scientific Advisors of the International Osteoporosis Foundation.
International Osteoporosis Foundation
No reports yet
Be the first to report this effect and help the community.
Add Bisphosphonates to your stack to report effects
Osteoporosis and osteoporosis therapies as determinants of implant fixation failure in arthroplasty and spinal fusion constructs: a position statement from the Fracture Working Group of the Council of Scientific Advisors of the International Osteoporosis Foundation.
International Osteoporosis Foundation
Related health conditions
Research showing how this habit affects specific health conditions. Always consult healthcare professionals.
May Help With
Low bone density increasing fracture risk
Long-Term Use of Bisphosphonates in Osteoporosis
Adler RA et al.
Effect of bisphosphonates on orthodontic tooth movement: an umbrella review.
StatPearls
Time to Benefit of Bisphosphonate Therapy for the Prevention of Nonvertebral Fractures in Postmenopausal Women With Osteoporosis
Liu J et al.
Osteoporosis and osteoporosis therapies as determinants of implant fixation failure in arthroplasty and spinal fusion constructs: a position statement from the Fracture Working Group of the Council of Scientific Advisors of the International Osteoporosis Foundation.
International Osteoporosis Foundation
Reconsidering the Benefits of Osteoporosis Treatment: The Case of Bisphosphonates.
Cummings SR et al.
Research (5 studies)
Effect of bisphosphonates on orthodontic tooth movement: an umbrella review.
StatPearls
Osteoporosis and osteoporosis therapies as determinants of implant fixation failure in arthroplasty and spinal fusion constructs: a position statement from the Fracture Working Group of the Council of Scientific Advisors of the International Osteoporosis Foundation.
International Osteoporosis Foundation
Reconsidering the Benefits of Osteoporosis Treatment: The Case of Bisphosphonates.
Cummings SR et al.
Time to Benefit of Bisphosphonate Therapy for the Prevention of Nonvertebral Fractures in Postmenopausal Women With Osteoporosis
Liu J et al.
Long-Term Use of Bisphosphonates in Osteoporosis
Adler RA et al.
Community updates
No updates yet for this supplement.
Be the first to share your experience!